Archives: Agenda

Priority benefits & “must-have” claims: Which health outcomes drive choice today (e.g., high protein/satiety, gut health/probiotics, immunity, bone & muscle health, heart health, weight management), and how do these vary by consumer segment and occasion? 

Sugar, fat and “naturalness” trade-offs: How are shoppers balancing low/zero sugar, reduced fat vs. full-fat, clean label/minimally processed, and “no artificial” expectations—and where are they willing to compromise for taste? 

Functional formats & ingredient credibility: What formats are winning (drinkable, Greek/skyr, fortified milks, kefir, cottage cheese, kids’ dairy) and which ingredients are most trusted (live cultures, vitamin D/calcium, lactase, fiber, omega-3, collagen)? 

Proof, regulation and communication: What level of evidence do consumers expect, which claims feel believable vs. overreaching, and how should brands communicate benefits on-pack and through digital without triggering skepticism? 

Authenticity, transparency, and verifiability of environmental claims 

• How are brands using marketing to appear sustainable? 

• Do consumers “talk the talk” but not “walk the walk”? 

• Genuine planet-proofing: Ensuring verifiable actions that reduce environmental harm across the product’s entire life cycle 

• What is the commitment of businesses to ESG? 

• Develop loyalty programs that reward repeat customers
• Foster emotional connections through storytelling
• Utilize data analytics to understand and predict consumer behavior

• CO₂ recovery and reuse solutions tailored for breweries
• Improve safety and monitoring with smart control and detection systems
• Reduce CO₂ purchasing, stabilize supply, and lower environmental impact

Senior representative, LogiCo2

• Exemption list and mandatory list
• Regulations for clinical investigation
• Interaction with registration timeline
• Differences in EU and China

• Eclevar delivers ultra-specialized MedTech CRO services in Cardiovascular, Wound, and Orthopaedic areas, easing clinical trials with expert compliance and cost-effective strategies
• Milo empowers tech-enabled solutions like EDC, eCOA, and innovative patient screening identification, reducing complexity and accelerating trial processes for smarter outcomes

• See how to align robust clinical evidence for MDR from an NB perspective
• Bridge the gap between reviewer expectations and sponsor realities
• Optimize clinical trial design and submissions for smoother approval

Chair: Dominic Tong, Senior Analyst, Medical Devices, GlobalData

• Planning modular PMPF studies to generate evidence supporting claim refinement, new use settings, or population expansion
• Addressing gaps from initial submissions and identifying operational challenges
• Leveraging AI tools to streamline post-market data collection, identifying emerging risks earlier, and improving interpretation of real-world performance
• Using PMPF outcomes to support intended purpose expansion and/or claim updates